User menu

Multicentric parallel phase II trial of the polo-like kinase 1 inhibitor BI 2536 in patients with advanced head and neck cancer, breast cancer, ovarian cancer, soft tissue sarcoma and melanoma : the first protocol of the European Organization for Research and Treatment of Cancer (EORTC) Network Of Core Institutes (NOCI)

Bibliographic reference Schöffski, Patrick ; Blay, Jean-Yves ; De Greve, Jacques ; Brain, Etienne ; Machiels, Jean-Pascal ; et. al. Multicentric parallel phase II trial of the polo-like kinase 1 inhibitor BI 2536 in patients with advanced head and neck cancer, breast cancer, ovarian cancer, soft tissue sarcoma and melanoma : the first protocol of the European Organization for Research and Treatment of Cancer (EORTC) Network Of Core Institutes (NOCI). In: European Journal of Cancer, Vol. 46, no. 12, p. 2206-2215 (2010)
Permanent URL http://hdl.handle.net/2078.1/33553